Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00246272
Status:
COMPLETED
Last Update Posted:
2010-04-27
First Post:
2005-10-28
Brief Title:
An Open-label Study Evaluating the Maintenance of Clinical Effect in Adult Schizophrenia Patients Switched From Risperidone Tablets to an Equivalent Dose of a Rapidly-dissolving Tablet Formulation of Risperdone
Sponsor:
Janssen-Ortho Inc Canada
Organization:
Janssen-Ortho Inc Canada